Too Sensitive or Just Right?: A Comparison of Two ALK Antibodies (D5F3 and ALK1) for Assessment of Anaplastic Large Cell Lymphoma. Issue 2 (28th April 2022)
- Record Type:
- Journal Article
- Title:
- Too Sensitive or Just Right?: A Comparison of Two ALK Antibodies (D5F3 and ALK1) for Assessment of Anaplastic Large Cell Lymphoma. Issue 2 (28th April 2022)
- Main Title:
- Too Sensitive or Just Right?
- Authors:
- Martin, Dana
Smith, Steven C
Chesney, Alden
Jackson-Cook, Colleen
Pillappa, Raghavendra - Abstract:
- Abstract: Objectives: To compare the performance of the rabbit monoclonal antihuman CD246 antibody (D5F3 clone) with the established ALK1 clone for immunohistochemical assessment of anaplastic large cell lymphoma (ALCL). Methods: Archival cases of ALCL (n = 27) were assessed immunohistochemically by use of ALK1 and D5F3 clones under standard Clinical Laboratory Improvement Amendments–compliant conditions. The intensity of cytoplasmic staining (0 = none; 1 = faint; 2 = moderate; 3+ = strong) and proportion of neoplastic cells (0%, <5%, 5%-50%, >50%) were evaluated and compared with clinical ALK break-apart fluorescence in situ hybridization (FISH) assays. Results: Nine ALCL specimens were positive for ALK expression by ALK1 staining (33%; 1 = 1+; 0 = 2+; 8 = 3+), while 14 were positive by D5F3 staining (48%; 3 = 1+; 1 = 2+; 10 = 3+). Across the cohort, D5F3 staining showed a significantly greater proportion of cells staining positive ( P = .02) and greater intensity ( P = .03). Of 3 cases positive for D5F3 only with FISH results, none showed rearrangements, although 1 showed copy number gains at the ALK locus in a subset of cells. Conclusions: Overall, D5F3 showed greater stain intensity and proportion staining than ALK1 in ALK-positive ALCL cases, which is especially helpful in limited samples. Caution and consideration of orthogonal ALK testing types is recommended, especially for cases with weak or focal staining.
- Is Part Of:
- American journal of clinical pathology. Volume 158:Issue 2(2022)
- Journal:
- American journal of clinical pathology
- Issue:
- Volume 158:Issue 2(2022)
- Issue Display:
- Volume 158, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 158
- Issue:
- 2
- Issue Sort Value:
- 2022-0158-0002-0000
- Page Start:
- 283
- Page End:
- 290
- Publication Date:
- 2022-04-28
- Subjects:
- Anaplastic lymphoma kinase -- ALK -- Anaplastic large cell lymphoma -- ALCL -- Immunohistochemistry -- IHC -- Fluorescence in situ hybridization -- FISH
Diagnosis, Laboratory -- Periodicals
Pathology -- Periodicals
616.07 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
http://ajcp.oxfordjournals.org/ ↗ - DOI:
- 10.1093/ajcp/aqac043 ↗
- Languages:
- English
- ISSNs:
- 0002-9173
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0824.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22919.xml